Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : CGEN save search
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
Published: 2024-04-10 (Crawled : 13:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -2.97%
H: 0.0%
C: 0.0%
com503 cancer research immunology potential
Compugen to Participate in Two Upcoming April 2024 Investor Conferences
Published: 2024-04-03 (Crawled : 12:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 0.85%
H: 3.18%
C: 2.97%
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -1.36%
H: 4.48%
C: -4.14%
symposium cancer immunotherapy
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024
Published: 2024-03-06 (Crawled : 12:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 3.92%
H: 1.81%
C: -3.4%
pipeline
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024
Published: 2024-02-26 (Crawled : 16:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -0.85%
H: 10.34%
C: 10.34%
conference biopharma global
Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024
Published: 2024-02-20 (Crawled : 12:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -0.83%
H: 3.36%
C: 0.84%
year results
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
Published: 2024-02-15 (Crawled : 12:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 0.0%
H: 2.61%
C: 0.87%
CCCC | $6.91 0.58% 0.58% 1.1M
|
Health Technology
|
| O: 2.46%
H: 7.54%
C: 5.47%
medical
Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
Published: 2024-01-08 (Crawled : 12:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 2.29%
H: 8.38%
C: 4.47%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.28%
H: 0.99%
C: 0.93%
first million payment astrazeneca cancer trial milestone
Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
Published: 2023-12-19 (Crawled : 12:30) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 178.08%
H: 21.18%
C: -1.48%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.5%
H: 0.99%
C: 0.43%
first payment astrazeneca cancer trial milestone
Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503, Novel Immuno-Oncology Pre-Clinical Program Harnessing IL-18 Biology
Published: 2023-12-19 (Crawled : 12:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 178.08%
H: 21.18%
C: -1.48%
com503 conference pre-clinical license il-18 program agreement
Compugen Reports Third Quarter 2023 Results
Published: 2023-11-07 (Crawled : 12:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: -5.83%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.59%
H: 0.46%
C: -0.09%
results
Compugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity in Patients Typically Not Responding to Immunotherapy
Published: 2023-11-06 (Crawled : 19:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 4.42%
H: 2.0%
C: -6.55%
com701 immunotherapy
Compugen Announces Receipt of Nasdaq Minimum Bid Price Notification
Published: 2023-11-03 (Crawled : 21:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
| Email alert
Add to watchlist
nasdaq
Compugen to Present New Data at SITC 2023 Suggesting Leading Edge of Anti-IL18 Binding Protein Antibody, COM503, in Treating Cancer
Published: 2023-10-31 (Crawled : 20:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 5.33%
H: 5.34%
C: 5.34%
il18 cancer protein
Compugen to Release Third Quarter 2023 Results on Tuesday, November 7, 2023
Published: 2023-10-24 (Crawled : 11:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -3.0%
H: 10.62%
C: 9.73%
results
Compugen to Present at Single Cell Genomics 2023 Meeting
Published: 2023-10-03 (Crawled : 13:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -3.0%
H: 3.09%
C: -1.21%
genomics cell meeting
Compugen Expands Intellectual Property with New Japanese Patent for the Triple Combination of any Anti-PVRIG, TIGIT and PD-1 Antibody for the Treatment of Cancer
Published: 2023-10-02 (Crawled : 17:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 0.0%
H: 6.45%
C: 3.23%
patent antibody cancer treatment
Compugen to Present New Clinical and Pre-Clinical Data in Multiple Presentations at SITC 2023
Published: 2023-09-27 (Crawled : 14:30) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -0.5%
H: 1.5%
C: -2.97%
pre-clinical
Compugen to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-08-31 (Crawled : 11:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 0.88%
H: 2.61%
C: -0.87%
conference global
Compugen Reports Second Quarter 2023 Results
Published: 2023-08-07 (Crawled : 11:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -8.04%
results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.